Connect
MJA
MJA

Managing Barrett's oesophagus

Geoffrey S Hebbard and Sanjay Nandurkar
Med J Aust 2004; 180 (8): . || doi: 10.5694/j.1326-5377.2004.tb05987.x
Published online: 19 April 2004

Can chemoprevention reduce the risk of progression to malignancy?

  • Geoffrey S Hebbard1
  • Sanjay Nandurkar2

  • 1 Department of Gastroenterology, Royal Melbourne Hospital, Melbourne, VIC.
  • 2 Department of Gastroenterology, Box Hill Hospital, Box Hill, VIC.

Correspondence: 

Competing interests:

G S H has acted as a consultant to AstraZeneca, Novartis and Pharmacia (Pfizer), and has received research support, sponsored travel and honoraria for speaking from AstraZeneca, Novartis and Wyeth. S N has acted in an advisory capacity to Pharmacia and has received research support, sponsored travel and honoraria for speaking from AstraZeneca and Pharmacia (Pfizer).

Author

remove_circle_outline Delete Author
add_circle_outline Add Author

Comment
Do you have any competing interests to declare? *

I/we agree to assign copyright to the Medical Journal of Australia and agree to the Conditions of publication *
I/we agree to the Terms of use of the Medical Journal of Australia *
Email me when people comment on this article

Online responses are no longer available. Please refer to our instructions for authors page for more information.